| Hans-Günter Meyer-Thompson | Hepatitiden
Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis.
Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis.
Balaceanu LA.
World J Clin Cases. 2019 Jun 26;7(12):1367-1382. doi: 10.12998/wjcc.v7.i12.1367.